Who invested in Innocrin Pharmaceuticals?
Innocrin Pharmaceuticals's investors include Eshelman Ventures.
United States · Series D startup
2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$36Mraised across 2 rounds since 2014, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $28M sold, first sale Apr 2015
No investor was named in the report.
From a historical funding recordSEC filing: $8.0M sold, first sale Nov 2014
Innocrin Pharmaceuticals's investors include Eshelman Ventures.
Innocrin Pharmaceuticals has raised $36M across 2 rounds since 2014.
Innocrin Pharmaceuticals's most recent round was a Series D of $28M in Apr 2015.
Its most recent round, $28M in Apr 2015, is also its largest on record.
Innocrin Pharmaceuticals's first round on record, in Apr 2015, was backed by Eshelman Ventures.
Innocrin Pharmaceuticals's latest named round is a Series D, in Apr 2015.
Innocrin Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.